Advertisement
For postmenopausal women with osteoporosis

ASBMR: Romosozumab Linked to Reduced Fracture Risk

0
Reduced vertebral fracture risk at 12 months among postmenopausal women with osteoporosis
Codeine is unsafe for children and should no longer be given to them

AAP Says Codeine Not Safe for Children, Urges Restrictions

0
Doctors should avoid giving drug to children undergoing tonsillectomy, adenoidectomy
Exondys 51 (eteplirsen) injection has been approved by the U.S. Food and Drug Administration for certain patients with Duchenne muscular dystrophy. It is the first drug to gain FDA approval for the condition.

FDA Approves First Drug for Duchenne Muscular Dystrophy

0
Exondys 51 sanctioned for patients with mutation of the dystrophin gene amenable to exon 51 skipping
For American-Indians with type 2 diabetes

Early Rx With Losartan Doesn’t Slow Kidney Disease Progression

0
Findings in American-Indians with type 2 diabetes and urine albumin/creatinine ratio <300 mg/g
Advising patients with asthma to take probiotics does not reduce antibiotic use

Recommending Oral Probiotics Doesn’t Cut Antibiotic Use

0
Advice to take probiotics has no effect for patients with asthma in U.K. primary care setting
For patients with chronic chilblains

Nifedipine Not Superior to Placebo for Chronic Chilblains

0
No significant improvements in mean visual analogue scale scores on complaints, disability
For hypogonadal men with prostate cancer

Testosterone Seems Safe for Hypogonadal Prostate CA Patients

0
Testosterone therapy seems oncologically safe after treatment or for those on active surveillance
For patients with or without dysglycemia or metabolic syndrome

Evolocumab Safe, Effective for Those With Dysglycemia, MetS

0
Reduction in LDL-C in all subgroups, including those with, without dysglycemia and metabolic syndrome
Engaging Americans at high risk for cardiovascular disease in aggressive efforts to lower their blood pressure could save more than 100

Tighter Systolic BP Control Could Save 100K U.S. Lives Annually

0
Findings indicate high-risk adults would benefit from intensive program to lower SBP to 120 or less
Semaglutide is noninferior to placebo for patients with type 2 diabetes at high cardiovascular risk

Rate of CVD Mortality, MI, Stroke Down for Patients on Semaglutide

0
Study confirms the noninferiority of semaglutide